Kodiak Sciences Financial Statements
NASDAQ: KODHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
99.87+5.61 (+5.95%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kodiak Sciences revenue and earnings
Kodiak Sciences reported a net loss of $230.0 million, compared with a loss of $176.2 million a year earlier. Diluted earnings per share came in at -$4.32.
Summary generated from market data by MetaCap's automated system. Methodology
Kodiak Sciences income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses | 234.39M | 186.85M | 277.32M | 341.38M | 267.05M | 136.01M | 49.19M | 26.37M | 25.52M | 17.15M |
| Research & Development | 182.37M | 126.09M | 206.30M | 267.59M | 217.34M | 107.39M | 37.51M | 18.79M | 22.02M | 14.05M |
| Operating Income | -234.39M | -186.85M | -277.32M | -341.38M | -267.05M | -136.01M | -49.19M | -26.37M | -25.52M | -17.15M |
| Interest Expense | 0 | 0 | 13.00K | 18.00K | 47.00K | 25.00K | 8.00K | 5.52M | 1.19M | 6.00K |
| Other Income (Expense) | -96.00K | -506.00K | 110.00K | 503.00K | -190.00K | -30.00K | 265.00K | -4.69M | -1.26M | 25.00K |
| Pretax Income | -229.91M | -176.19M | -260.43M | -333.79M | -266.92M | -133.08M | -47.37M | -41.44M | -27.94M | -17.13M |
| Income Tax | 52.00K | 20.00K | 33.00K | 33.00K | 74.00K | 14.00K | — | — | — | — |
| Net Income | -229.97M | -176.21M | -260.49M | -333.82M | -266.99M | -133.10M | -47.37M | -41.44M | -27.94M | -17.13M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | -4.32 | -3.35 | -4.97 | -6.39 | -5.16 | -2.91 | -1.25 | -2.77 | -3.72 | -2.38 |
| EPS (Diluted) | -4.32 | -3.35 | -4.97 | -6.39 | -5.16 | -2.91 | -1.25 | -2.77 | -3.72 | -2.38 |
| Shares Outstanding (Basic) | 53.21M | 52.58M | 52.41M | 52.25M | 51.79M | 45.74M | 37.85M | 14.98M | 7.52M | 7.21M |
| Shares Outstanding (Diluted) | 53.21M | 52.58M | 52.41M | 52.25M | 51.79M | 45.74M | 37.85M | 14.98M | 7.52M | 7.21M |
| EBITDA | -216.06M | -168.14M | -259.02M | -337.58M | -266.05M | -135.53M | -48.65M | -25.88M | -24.97M | -16.89M |
This table shows 10 annual periods of Kodiak Sciences's income statement, from FY 2025 back to FY 2016, across 13 line items including operating expenses, research & development, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow KOD's reporting calendar. What is a income statement?